Results 181 to 190 of about 306,427 (235)

Evolving strategies in obstructive hypertrophic cardiomyopathy: myosin inhibitors as monotherapy compared with beta-blockers. [PDF]

Heart Fail Rev
Grupper A, Sverdlov AL, Cheema BS, Nasrollahizadeh A, Hosseini K.   +4 more
europepmc   +1 more source

Outcomes After Repeat Alcohol Septal Ablation in Patients With Obstructive Hypertrophic Cardiomyopathy. [PDF]

JACC Adv
Hiruma T, Kitamura M, Takamisawa I, Abe R, Kawai T, Funaki T, Izumi Y, Higuchi R, Matsuda J, Tokita Y, Nanasato M, Iguchi N, Iwakura T, Shimokawa T, Takanashi S, Takayama H, Shimada YJ, Takano H, Asai K, Isobe M, Takayama M.   +20 more
europepmc   +1 more source

Efficacy of high-dose carvedilol treatment for cats with stage B1 obstructive hypertrophic cardiomyopathy. [PDF]

J Feline Med Surg
Satomi S, Suzuki R, Yuchi Y, Kanno H, Inoue M, Teshima T, Matsumoto H.   +6 more
europepmc   +1 more source

Efficacy and safety of mavacamten in non-obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis of randomized trials. [PDF]

Int J Cardiol Heart Vasc
Abdullah M, Thalib HI, Tahir MB, Khalid N, Mushtaq A, Afzal MA, Moore MD, Sharma N, Muddassir S, Ayers MP, Albaghdadi M, Aronow WS.   +11 more
europepmc   +1 more source

Mavacamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy During Active Chemotherapy. [PDF]

JACC Case Rep
Caro-Codón J, Valbuena-López S, Ghanem Cañete I, Pérez Wert JP, Refoyo E, Fernández García-Moya L, Saldaña-García J, Paños-Babin M, Moreno R, López-Fernández T.   +9 more
europepmc   +1 more source

Paradoxical Rise in Pulmonary Artery Pressure Following Successful Mavacamten Therapy for Obstructive Hypertrophic Cardiomyopathy: A Case Report. [PDF]

Clin Case Rep
Zhang M.
europepmc   +1 more source